Shenandoah Therapeutics Appoints Steve Worland, Ph.D., as Chief Executive Officer
For best results when printing this announcement, please click on link below: Shenandoah Therapeutics Appoints Steve Worland, Ph.D., as Chief Executive Officer Co-Founder and founding CEO Isabella Graef, M.D., transitions to Chief Scientific Officer Lead oncology program advancing toward IND-enabling studies following